tirzepatide bone mineral density Recent Updates on Diabetes and GLP-1 Agonists and Orthopedic Surgery:

The key point is that this is the first randomized, placebo-controlled clinical evidence that a GLP-1 receptor agonist may slow the biological processes associated with aging in humans. Michael Corley, PhD Using multiple epigenetic clocks, we saw a broad pattern of slower biological aging in participants treated with semaglutide compared with placebo, including a 9% slowing in the pace of aging measured by DunedinPACE and a significant effect on PCGrimAge, which tracks processes linked to all-cause mortality and age-related disease, the researcher detailed

Consequently, it aids in weight loss

Semaglutide is a synthetic research peptide that interacts with GLP1 (glucagonlike peptide1) receptors , which are key components in metabolic signaling pathways

There are several injections that can be used for weight loss

Your prescribing healthcare provider can explain how to give yourself a semaglutide injection and tell you how much semaglutide to take each week